Antenatal magnesium sulfate to prevent cerebral palsy

Amy K. Keir, Emily Shepherd, Sarah McIntyre, Alice Rumbold, Charlotte Groves, Caroline Crowther, Emily Joy Callander

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Magnesium sulfate given to women before birth at <30 weeks' gestation reduces the risk of cerebral palsy in their children. Our study aimed to assess the impact of a local quality improvement programme, primarily using plan-do-study-act cycles, to increase the use of antenatal magnesium sulfate. After implementing our quality improvement programme, an average of 86% of babies delivered at <30 weeks' gestation were exposed to antenatal magnesium sulfate compared with a historical baseline rate of 63%. Our study strengthens the case for embedding quality improvement programmes in maternal perinatal care to reduce the impact of cerebral palsy on families and society.

Original languageEnglish
Pages (from-to)F225-F227
JournalArchives of Disease in Childhood: Fetal and Neonatal Edition
Volume107
Issue number2
DOIs
Publication statusPublished or Issued - 1 Mar 2022

Keywords

  • health services research
  • neonatology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology

Cite this